Rhenman & Partners Asset Management AB as of Sept. 30, 2020
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 82 positions in its portfolio as reported in the September 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
BioMarin Pharmaceutical (BMRN) | 5.0 | $57M | 744k | 76.08 | |
Horizon Therapeutics Pub SHS | 4.8 | $54M | 695k | 77.68 | |
Novocure Ltd Reg Ord Shs (NVCR) | 4.1 | $46M | 410k | 111.31 | |
UnitedHealth (UNH) | 3.0 | $34M | 110k | 311.77 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.7 | $30M | 110k | 272.12 | |
Guardant Health (GH) | 2.4 | $27M | 240k | 111.78 | |
Myokardia | 2.3 | $26M | 190k | 136.33 | |
Cigna Corp (CI) | 2.3 | $25M | 150k | 169.41 | |
Alexion Pharmaceuticals | 2.2 | $25M | 220k | 114.43 | |
Humana (HUM) | 2.2 | $25M | 60k | 413.88 | |
Abbvie (ABBV) | 2.2 | $25M | 280k | 87.59 | |
Eli Lilly & Co. (LLY) | 2.2 | $24M | 165k | 148.02 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.2 | $24M | 170k | 142.59 | |
Anthem (ELV) | 2.1 | $24M | 90k | 268.59 | |
Axonics Modulation Technolog (AXNX) | 2.1 | $24M | 460k | 51.04 | |
Livongo Health | 2.1 | $23M | 167k | 140.05 | |
Medtronic SHS (MDT) | 2.0 | $23M | 221k | 103.92 | |
Abbott Laboratories (ABT) | 2.0 | $22M | 205k | 108.83 | |
Cooper Cos Com New | 1.8 | $20M | 60k | 337.12 | |
Biohaven Pharmaceutical Holding | 1.8 | $20M | 310k | 65.01 | |
Abiomed | 1.7 | $19M | 70k | 277.06 | |
Mirati Therapeutics | 1.7 | $19M | 114k | 166.05 | |
Immunomedics | 1.7 | $19M | 221k | 85.03 | |
Gilead Sciences (GILD) | 1.6 | $18M | 290k | 63.19 | |
Centene Corporation (CNC) | 1.6 | $18M | 300k | 58.33 | |
Bristol Myers Squibb (BMY) | 1.6 | $18M | 290k | 60.29 | |
Boston Scientific Corporation (BSX) | 1.5 | $17M | 450k | 38.21 | |
Esperion Therapeutics (ESPR) | 1.5 | $17M | 455k | 37.17 | |
Nektar Therapeutics (NKTR) | 1.5 | $17M | 1.0M | 16.59 | |
Acceleron Pharma | 1.5 | $16M | 145k | 112.53 | |
Macrogenics (MGNX) | 1.4 | $16M | 636k | 25.19 | |
Arena Pharmaceuticals Com New | 1.4 | $16M | 211k | 74.79 | |
Alnylam Pharmaceuticals (ALNY) | 1.3 | $15M | 100k | 145.60 | |
CVS Caremark Corporation (CVS) | 1.2 | $14M | 240k | 58.40 | |
Seattle Genetics | 1.2 | $14M | 70k | 195.69 | |
Merck & Co (MRK) | 1.2 | $13M | 160k | 82.95 | |
Thermo Fisher Scientific (TMO) | 1.2 | $13M | 30k | 441.53 | |
Regeneron Pharmaceuticals (REGN) | 1.1 | $13M | 23k | 559.78 | |
Baxter International (BAX) | 1.1 | $13M | 155k | 80.42 | |
Intra Cellular Therapies (ITCI) | 1.1 | $12M | 475k | 25.66 | |
Iovance Biotherapeutics (IOVA) | 1.0 | $11M | 340k | 32.92 | |
Zimmer Holdings (ZBH) | 1.0 | $11M | 82k | 136.13 | |
Xencor (XNCR) | 0.9 | $10M | 260k | 38.79 | |
Aerie Pharmaceuticals | 0.9 | $10M | 850k | 11.77 | |
Edwards Lifesciences (EW) | 0.9 | $9.6M | 120k | 79.82 | |
Livanova SHS (LIVN) | 0.8 | $9.5M | 210k | 45.21 | |
Silk Road Medical Inc Common | 0.8 | $9.4M | 140k | 67.21 | |
Biogen Idec (BIIB) | 0.8 | $9.4M | 33k | 283.67 | |
Hca Holdings (HCA) | 0.8 | $9.4M | 75k | 124.68 | |
Intuitive Surgical Com New (ISRG) | 0.8 | $8.5M | 12k | 709.50 | |
EXACT Sciences Corporation (EXAS) | 0.7 | $8.2M | 80k | 101.95 | |
Becton, Dickinson and (BDX) | 0.7 | $8.1M | 35k | 232.69 | |
Neurocrine Biosciences (NBIX) | 0.6 | $7.2M | 75k | 96.16 | |
Glaukos (GKOS) | 0.6 | $6.9M | 140k | 49.52 | |
Apellis Pharmaceuticals (APLS) | 0.6 | $6.8M | 225k | 30.17 | |
Adverum Biotechnologies | 0.6 | $6.4M | 625k | 10.30 | |
Sangamo Biosciences (SGMO) | 0.6 | $6.4M | 675k | 9.45 | |
Fibrogen (FGEN) | 0.5 | $6.0M | 145k | 41.12 | |
Accolade (ACCD) | 0.5 | $5.9M | 152k | 38.87 | |
Bluebird Bio (BLUE) | 0.5 | $5.8M | 108k | 53.95 | |
Revance Therapeutics (RVNC) | 0.5 | $5.5M | 220k | 25.14 | |
Myovant Sciences | 0.5 | $5.3M | 380k | 14.05 | |
Alkermes SHS (ALKS) | 0.5 | $5.1M | 310k | 16.57 | |
Ultragenyx Pharmaceutical (RARE) | 0.4 | $5.1M | 62k | 82.20 | |
Meiragtx Holdings (MGTX) | 0.4 | $5.0M | 375k | 13.24 | |
Shockwave Med | 0.4 | $4.5M | 60k | 75.80 | |
Rigel Pharmaceuticals Com New | 0.4 | $4.2M | 1.7M | 2.40 | |
Dynavax Technologies Corp Com New (DVAX) | 0.4 | $4.0M | 926k | 4.32 | |
Radius Health Com New | 0.3 | $3.8M | 332k | 11.34 | |
Incyte Corporation (INCY) | 0.3 | $3.6M | 40k | 89.75 | |
Epizyme | 0.3 | $3.2M | 265k | 11.93 | |
Agios Pharmaceuticals (AGIO) | 0.3 | $3.2M | 90k | 35.00 | |
Viewray (VRAYQ) | 0.2 | $2.7M | 775k | 3.50 | |
Cellectis S A Spons Ads (CLLS) | 0.2 | $2.7M | 145k | 18.50 | |
G1 Therapeutics | 0.2 | $2.2M | 190k | 11.55 | |
Uniqure Nv SHS (QURE) | 0.1 | $1.5M | 41k | 36.82 | |
Amarin Corp Spons Adr New (AMRN) | 0.1 | $1.3M | 300k | 4.21 | |
Abeona Therapeutics | 0.1 | $944k | 925k | 1.02 | |
Pieris Pharmaceuticals | 0.1 | $621k | 300k | 2.07 | |
Qualcomm (QCOM) | 0.0 | $280k | 2.4k | 117.60 | |
Chevron Corporation (CVX) | 0.0 | $214k | 3.0k | 71.96 | |
Ford Motor Company (F) | 0.0 | $194k | 29k | 6.65 |